Craig A. McElroy

Image
Craig McElroy

Craig A. McElroy, PhD

Title
Research Assistant Professor
Unit / Department / Division
Medicinal Chemistry and Pharmacognosy
Email Address
Phone Number

Journal Articles

Abdelhameed A, Feng M, Joice AC, Zywot EM, Jin Y, La Rosa C, Liao X, Meeds HL, Kim Y, Li J, McElroy CA, Wang MZ, Werbovetz KA. Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl Linker. ACS Infect Dis. 2021 Jul 9;7(7):1901-1922. doi: 10.1021/acsinfecdis.0c00855. Epub 2021 Feb 4. PMID: 33538576.

Persaud AK, Nair S, Rahman MF, Raj R, Weadick B, Nayak D, McElroy C, Shanmugam M, Knoblaugh S, Cheng X, Govindarajan R. Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors. Nat Commun. 2021 Feb 23;12(1):1248. doi: 10.1038/s41467-021-21451-6. PMID: 33623001; PMCID: PMC7902824.

Corrigan TS, Lotti Diaz LM, Border SE, Ratigan SC, Kasper KQ, Sojka D, Fajtova P, Caffrey CR, Salvesen GS, McElroy CA, Hadad CM, Doğan Ekici Ö. Design, synthesis, and <i>in vitro</i> evaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1387-1402. doi: 10.1080/14756366.2020.1781107. PMID: 32633155; PMCID: PMC7470110.

Venkataraman L, Fair SR, McElroy CA, Hester ME, Fu H. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease. Stem Cell Rev Rep. 2020 Nov 12:1–22. doi: 10.1007/s12015-020-10068-9. Epub ahead of print. PMID: 33180261; PMCID: PMC7658915.

Fair SR, Julian D, Hartlaub AM, Pusuluri ST, Malik G, Summerfied TL, Zhao G, Hester AB, Ackerman WE 4th, Hollingsworth EW, Ali M, McElroy CA, Buhimschi IA, Imitola J, Maitre NL, Bedrosian TA, Hester ME. Electrophysiological Maturation of Cerebral Organoids Correlates with Dynamic Morphological and Cellular Development. Stem Cell Reports. 2020 Oct 13;15(4):855-868. doi: 10.1016/j.stemcr.2020.08.017. Epub 2020 Sep 24. PMID: 32976764; PMCID: PMC7562943.

Kackley ML, Short JA, Hyde PN, LaFountain RA, Buga A, Miller VJ, Dickerson RM, Sapper TN, Barnhart EC, Krishnan D, McElroy CA, Maresh CM, Kraemer WJ, Volek JS. A Pre-Workout Supplement of Ketone Salts, Caffeine, and Amino Acids Improves High-Intensity Exercise Performance in Keto-Naïve and Keto-Adapted Individuals. J Am Coll Nutr. 2020 May-Jun;39(4):290-300. doi: 10.1080/07315724.2020.1752846. Epub 2020 Apr 24. PMID: 32330107.

McGarry KG, Lalisse RF, Moyer RA, Johnson KM, Tallan AM, Winters TP, Taris JE, McElroy CA, Lemmon EE, Shafaat HS, Fan Y, Deal A, Marguet SC, Harvilchuck JA, Hadad CM, Wood DW. A Novel, Modified Human Butyrylcholinesterase Catalytically Degrades the Chemical Warfare Nerve Agent, Sarin. Toxicol Sci. 2020 Mar 1;174(1):133-146. doi: 10.1093/toxsci/kfz251. PMID: 31879758.

Dar MJ, Khalid S, McElroy CA, Satoskar AR, Khan GM. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes. Int J Pharm. 2020 Jan 5;573:118900. doi: 10.1016/j.ijpharm.2019.118900. Epub 2019 Nov 22. PMID: 31765786.

Abdelhameed A, Liao X, McElroy CA, Joice AC, Rakotondraibe L, Li J, Slebodnick C, Guo P, Wilson WD, Werbovetz KA. Synthesis and antileishmanial evaluation of thiazole orange analogs. Bioorg Med Chem Lett. 2020 Jan 1;30(1):126725. doi: 10.1016/j.bmcl.2019.126725. Epub 2019 Oct 4. PMID: 31732409.

Dar MJ, McElroy CA, Khan MI, Satoskar AR, Khan GM. Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Deliv. 2020 Jan;17(1):97-110. doi: 10.1080/17425247.2020.1700227. Epub 2019 Dec 6. PMID: 31786952.